Not sure how after a Sale this issues are dealt with
Posts tagged Value Pickr
Bharat rasayan ltd (15-12-2015)
Bharat Group –
Comprises 3 companies : Bharat Rasayan Ltd. (BRL), Bharat Insecticides Ltd. and Bharat Agrotech Ltd.
Though in allied businesses of catering to agriculture industry, inter-company transactions / related party transaction are negligible – undermines good corporate governance. Total turnover of Bharat Group for FY2015 is Rs. 1035 cr. with BRL contributing majority of it at ~Rs. 470 crs.
Product –
BRL is manufacturer of Technical Grade Pesticide (TCP). Any pesticide has active ingredient and non-active ingredient. Active ingredient, also known as TCP, is a constituent working to destroy pests.
Non-active ingredient facilitates storage, transportation of product in totality. Basically, TCP is key raw material going into manufacturing of pesticide. TCP seem to be functional equivalent of OEMs to auto manufacturers. Link below gives more insights into TCP - http://www.vikalpa.com/pdf/articles/1990/1990_apr_jun_23_33.pdf
Capacity –
2 units at Mokhra (5000 MT) near Rohtak and Dahej (15000 MT) in Gujarat.
Dahej capacity commissioned in FY2013. It has filliped sales and profitability. Expansion was funded by debt. D/E increased to 2x in FY2013 from under 1x in FY2012.
Sales filliped from 97 crs. in FY2011 to 188 crs. in FY2013 and 439 crs. in FY2015.
Not sure why have OPM has tripled to 18% in FY2015 from 6% in FY2010
Certifications – BRL has ISO 9001:2008, ISO 14001:2004 and OHS 18001:2007 certification catalyzing long term partnership with institutional and foreign clients.
Clients – No meaningful data available. Will have to dig further.
Competition – very thick competitive space including companies like Kanoria Chemicals, Dhanuka Agrotech, Sabero Organics, Insecticides India, Camson Biotech, Kaveri, Rallis India etc.
Some concerns/aberrations –
1. Co. passed a resolution in FY2015 AGM to invest/advance loan/guarantee transaction up to Rs. 500 cr.
2. R&D expenditure as % of total expenses is too low (0.2%). Google search and some on-ground research suggests, TCP manufacturing involves lot of research to sustain
3. What are the growth drivers in coming years – expansion completed 3 years back, no new high margin products underway?
4. Raw material price risk – drivers of OPM?
Some highlights from AR read –
1. Foreign exchange earnings and outgo almost net each other, hedging exchange rate risk. This is consciously done by management.
2. Rising exports are mitigating vagaries of domestic monsoon – Exports as % of sales have risen from 20% (Rs. 27 crs.) in FY2012 to 30% (Rs. 117 crs.) in FY2014
3. No equity dilution over last decade while capacity quadrupled
Torrent Pharma Ltd (15-12-2015)
and stock price falling could just an icing on cake for investors to load on
Torrent Pharma Ltd (15-12-2015)
yes nexium is only recently launched, approval was on 19 oct 2015 and will take some time to get established. innovator astra zeneca still has around 60% market share.
the benefit in nexium is that a potential strong competitor in form of dr reddys is temporarily out of the field.
needs to be seen how torrent exploits this opportunity.
Ajanta Pharma (15-12-2015)
Please discuss portfolio related stuff in the portfolio thread. Do not clutter Ajanta thread.
Torrent Pharma Ltd (15-12-2015)
Thanks alot @hitesh2710 and @ankitgupta
Nexium looks pretty low. Is this because the data is from close to the launch by torrent?
Ajanta Pharma (15-12-2015)
Hi Santosh, Quite impressed with your work. Just for my learning, what made you exit Repco Home in spite of its consistent growth and big opportunity ahead.
Companies affected by Chennai Flood? (15-12-2015)
Can Take Solutions be a part of the above list?
Torrent Pharma Ltd (15-12-2015)
As per Bloomberg data, Torrent has market share of 12% in gDetrol and 1.3% in gNexium.
They have been able to capture good market share in Detrol post approval from USFDA.
Torrent Pharma Ltd (15-12-2015)
Just to add, in the last conf call Torrent had said that their real market share in Aripiprazole is 15% since some of their distributors do not report numbers. Would be interesting to know their numbers in Detrol and Nexium.
I am seriously impressed by Torrent's ability to garner market share.